Orion Corporation
Clinical trials sponsored by Orion Corporation, explained in plain language.
Orion is a Finnish pharmaceutical company developing and marketing drugs, including for CNS and respiratory diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a new pill outsmart resistant prostate cancer? Results expected Oct 2026 (estimated)